The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGlaxosmithkline Share News (GSK)

Share Price Information for Glaxosmithkline (GSK)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1,780.50
Bid: 1,778.50
Ask: 1,779.00
Change: 7.00 (0.39%)
Spread: 0.50 (0.028%)
Open: 1,780.00
High: 1,786.50
Low: 1,771.50
Prev. Close: 1,773.50
GSK Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

UPDATE 2-Healthcare, financials stocks drag FTSE 100 lower; DS Smith outperforms

Tue, 07th Sep 2021 09:28

(For a Reuters live blog on U.S., UK and European stock
markets, click LIVE/ or type LIVE/ in a news window)

* Broker TP ICAP slips as first-half profit falls

* UK PM raises taxes to tackle health crisis

* 888 in talks to buy William Hill's non-U.S. assets; shares
down

* FTSE 100 down 0.5%, FTSE 250 off 0.6%
(Updates to close)

By Devik Jain and Amal S

Sept 7 (Reuters) - London's FTSE 100 index ended lower on
Tuesday, weighed down by healthcare stocks and brokerages, while
DS Smith jumped to the top of the index after an upbeat trading
update.

The blue-chip index fell 0.5% and marked its worst
session in nearly three weeks, as healthcare
weighed with drugmakers AstraZeneca and GlaxoSmithKline
among top drags.

Investment banking and brokerage services providers
shed 1% after TP ICAP Group Plc reported a lower
half-year profit.. Shares of the world's largest
inter-dealer broker slipped 10.7%.

DS Smith jumped 2.8% to the top of the index as
J.P. Morgan raised its price target on the cardboard maker's
stock after it said trading continued to progress well in line
with the trends.

European stocks edged down as investors awaited the European
Central Bank's policy meeting on Thursday for clues on how the
crisis-fighting measures would be dismantled.

"After a weak US jobs report last Friday prompted
speculation the Federal Reserve would hold off on tapering
support for the economy, attention will switch to the European
Central Bank this week as it unveils its latest decision on
monetary policy on Thursday," said Russ Mould, investment
director at AJ Bell.

Meanwhile, British Prime Minister Boris Johnson set out
plans to raise taxes on workers, employers and some investors to
try to fix a health and social care funding crisis sending pound
down.

The domestically focused mid-cap FTSE 250 index was
down 0.6% dragged by industrial stocks.

Among individual stocks, 888 fell 1.8% after the
British gambling group said it was in advanced talks with
Caesars Entertainment for a possible acquisition of the
international operations of the U.S. company's William Hill
business.

Meggitt Plc fell 12.1% to the bottom of mid-cap
index after aerospace parts maker TransDigm bowed out of
an $8.7 billion takeover battle with fellow U.S. bidder
Parker-Hannifin for the British engineering firm.
(Reporting by Devik Jain and Amal S in Bengaluru; Editing by
Saumyadeb Chakrabarty and Uttaresh.V, Editing by William
Maclean)

More News
18 Dec 2023 10:07

GSK's dostarlimab trial in endometrial cancer meets primary endpoint

(Alliance News) - GSK PLC on Monday said a trial of dostarlimab in combination with niraparib for treating endometrial cancer has met its primary endpoint.

Read more
18 Dec 2023 07:55

LONDON BRIEFING: Games Workshop seals Amazon deal for Warhammer 40,000

(Alliance News) - Stocks in London were set to retreat slightly on Monday, in line with equity markets in Asia, at the start of the last week before the Christmas holidays.

Read more
18 Dec 2023 07:18

GSK sees success in Jemperli endometrial cancer trial

(Sharecast News) - GSK released positive headline results from the planned analysis of its trial of Jemperli in endometrial cancer on Monday.

Read more
17 Dec 2023 15:16

PRESS: GSK looks for deals in China as rebuilds relationship

(Alliance News) - The Financial Times on Sunday reported that GSK PLC is looking for some new deals in China.

Read more
15 Dec 2023 17:08

European shares end fifth week higher on rate-cut optimism

Barclays sees first ECB rate cut in April

*

Read more
15 Dec 2023 16:51

LONDON MARKET CLOSE: FTSE 100 underperforms as post-Fed rally cools

(Alliance News) - London's FTSE 100 ended lower on Friday, with profit-taking and some hawkish words from a US policymaker keeping equities in check at the end of a largely positive week for stocks.

Read more
15 Dec 2023 16:29

PRESS: GSK, Astra and AbbVie in US scrutiny over patents - Bloomberg

(Alliance News) - A US senator has accused AstraZeneca PLC, GSK PLC, AbbVie Inc and other drugmakers of "abusing" the patent system to send prices higher, Bloomberg reported on Thursday.

Read more
12 Dec 2023 10:08

AstraZeneca buys respiratory vaccine developer Icosavax in $1.1 bln deal

Dec 12 (Reuters) - AstraZeneca said on Tuesday it had agreed to buy respiratory syncytial virus (RSV) vaccine developer Icosavax in a deal valued at up to $1.1 billion.

Read more
12 Dec 2023 08:22

TOP NEWS: Japan accepts GSK's filing for respiratory disease vaccine

(Alliance News) - GSK PLC on Tuesday said Japan's Ministry of Health, Labour & Welfare has accepted its regulatory application for the extension of its respiratory syncytial virus vaccine, Arexvy, for adults aged 50-59.

Read more
12 Dec 2023 07:39

LONDON BRIEFING: UK unemployment unchanged at 4.2%; eyes on US CPI

(Alliance News) - Stocks in London are called to open higher, as investors digest the latest UK unemployment data, before turning their heads to US inflation.

Read more
12 Dec 2023 07:24

GSK seeks to extend RSV vaccine approval in Japan

(Sharecast News) - GSK announced on Tuesday that Japan's Ministry of Health, Labour and Welfare (MHLW) has accepted its regulatory application for the extension of the indication of its RSV vaccine to include adults aged 50- to 59 at an increased risk of contracting the disease.

Read more
11 Dec 2023 08:28

GSK drug gets EU marketing backing for form of endometrial cancer

(Alliance News) - GSK PLC on Monday said it won EU backing for its Jemperli drug in tandem with chemotherapy to treat a form of endometrial cancer.

Read more
11 Dec 2023 07:41

LONDON BRIEFING: GSK drug gets EU endorsement; Begbies backs outlook

(Alliance News) - London's FTSE 100 is called to open a touch lower on Monday, kicking off the week with some slight trepidation after Friday's hotter-than-expected US jobs report which offered the dollar some respite.

Read more
11 Dec 2023 07:23

GSK endometrial cancer treatment gets Europe authorisation

(Sharecast News) - GSK announced on Monday that the European Commission has granted marketing authorisation for 'Jemperli', or dostarlimab, in combination with chemotherapy for certain endometrial cancers.

Read more
7 Dec 2023 12:54

THG backer Kelso pushes for demerger to trim "inherent" valuation gap

(Alliance News) - THG PLC investor Kelso Group Holdings PLC on Thursday reiterated its call for a demerger, which the shareholder believes will help close the "disparity" between the e-commerce firm's share price and its true value.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.